Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 47.4% during mid-day trading on Saturday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares were traded during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company has a market capitalization of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock has a 50-day simple moving average of C$0.07 and a 200-day simple moving average of C$0.06.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Calculate Options Profits
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What Are Dividend Challengers?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 3 Stocks to Consider Buying in October
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
